Solidification studies of polyethylene glycols, gelucire 44/14 or their dispersions with triamterene or temazepam.
The solidification of polyethylene glycols (PEG 1500, PEG 2000, PEG 4000, PEG 6000), gelucire 44/14 or their dispersions containing triamterene or temazepam were studied to assess the feasibility of using these dispersions to liquid-fill hard gelatin capsules. Solidification from melts, investigated by differential scanning calorimetry using cooling cycles, showed a tendency of the drugs, carriers or their dispersions to supercool. The degree of supercooling depended on the rate of cooling, the drug content and, for the PEGs, on the molecular weight. PEG 1500 and PEG 2000 gave one morphological form, irrespective of cooling rate; PEG 4000 and PEG 6000 solidified into at least two forms, depending on the cooling rate. Incorporation of drugs affected the morphology of the PEGs during solidification. The rate of crystal growth was, furthermore, influenced by the fusion temperature, molecular weight and the degree of supercooling. The degree of crystallinity, as measured by the enthalpies of solidification, decreased with increasing cooling rate. The results show that reducing the rate of solidification could lead to incomplete solidification, giving products that are liable to change on storage.
Drug Delivery and Pharmaceutical Technology Group, School of Pharmacy and Chemistry, Liverpool John Moores University, UK.
S K
SK
Dordunoo
J L
JL
Ford
M H
MH
Rubinstein
D002152:Calorimetry, Differential Scanning; D002214:Capsules; D003460:Crystallization; D010592:Pharmaceutic Aids / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry*; D013693:Temazepam / Q000737:chemistry*; D013696:Temperature; D014223:Triamterene / Q000737:chemistry*
D002214:Capsules; D010592:Pharmaceutic Aids; C104509:gelucire 44-14; D011092:Polyethylene Glycols; D013693:Temazepam; D014223:Triamterene